Decreased bioavailability of digoxin due to antacids and kaolin-pectin.

Employing a Latin-square design and single-dose studies of bioavailability in 10 normal human volunteers, we tested the hypothesis that antacids and kaolin-pectin might interfere with the bioavailability of orally administered digoxin. Cumulative six-day urinary digoxin excretion (expressed as the percentage of a 0.75-mg dose recovered) was: control, 40.1+/-3.0 (S.E.); aluminum hydroxide, 30.7+/-2.9; magnesium hydroxide, 27.1+/-2.4; magnesium trisilicate, 29.1+/-1.7; and kaolin-pectin 23.4+/-2.0. The differences in means were highly significant (F = 10.47, P less than 0.005). Further analysis (multiple comparison test) revealed that control differed significantly from each of the other treatments (alpha = 0.05), but there was no such difference between any of the other treatment groups. The decreased cumulative excretion produced by antacids and kaolin-pectin reflected a striking reduction in digoxin absorption associated with these compounds that was not related to alteration of gut transit time or to adsorption of digoxin to these gastrointestinal medications.

[1]  C. Zukoski,et al.  The effect of jejunoileal bypass in patients with morbid obesity on the pharmacokinetics of digoxin (DIG) in man , 1976 .

[2]  S. A. Khalil,et al.  The uptake of digoxin and digitoxin by some antacids , 1974, The Journal of pharmacy and pharmacology.

[3]  D. Greenblatt,et al.  Bioavailability of digoxin tablets and elixir in the fasting and postprandial states , 1974, Clinical pharmacology and therapeutics.

[4]  J. Doherty,et al.  Tritiated digoxin. XXII. Absorption and excretion in malabsorption syndromes. , 1974, The American journal of medicine.

[5]  K. Hellström,et al.  The gastrointestinal absorption of digoxin in seven patients with gastric or small intestinal reconstructions. , 2009, Acta medica Scandinavica.

[6]  D. Greenblatt,et al.  Evaluation of digoxin bioavailability in single-dose studies. , 1973, The New England journal of medicine.

[7]  G. Abraham,et al.  Plasma digoxin levels in normal human volunteers following chronic oral and intramuscular administration. , 1973, The Journal of laboratory and clinical medicine.

[8]  B F Johnson,et al.  Rate of dissolution of digoxin tablets as a predictor of absorption. , 1973, Lancet.

[9]  L. J. Fischer,et al.  Effect of coadministration of aluminum and magnesium hydroxides on absorption of anticoagulants in man , 1973, Clinical pharmacology and therapeutics.

[10]  K. Hellström,et al.  The absorption of orally administered (12 - 3 H)digoxin in man. , 1972, Clinical science.

[11]  W. Heizer,et al.  Absorption of digoxin in patients with malabsorption syndromes. , 1971, The New England journal of medicine.

[12]  J. Caldwell,et al.  Intestinal absorption of digoxin-3H in the rat. , 1969, The American journal of physiology.

[13]  E. Haber,et al.  Determination of therapeutic and toxic serum digoxin concentrations by radioimmunoassay. , 1969, The New England journal of medicine.

[14]  J. P. Chen,et al.  Digoxin-specific antibodies. , 1967, Proceedings of the National Academy of Sciences of the United States of America.

[15]  S. M. Blaug,et al.  IN VITRO ADSORPTION OF SOME ANTICHOLINERGIC DRUGS BY VARIOUS ANTACIDS. , 1965, Journal of pharmaceutical sciences.

[16]  J. H. Torrie,et al.  Principles and procedures of statistics: McGraw-Hill Book Company, Inc. New York Toronto London. , 1960 .

[17]  I. W. Grote,et al.  Studies on antacids. IV. Adsorption effects of various aluminum antacids upon simultaneously administered anticholinergetic drugs. , 1953, Journal of the American Pharmaceutical Association. American Pharmaceutical Association.

[18]  B. Waisbren,et al.  Reduced Absorption of Aureomycin Caused by Aluminum Hydroxide Gel (Amphojel) , 1950, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.